GSVD comparison of patient-matched normal and tumor aCGH profiles reveals global copy-number alterations predicting glioblastoma multiforme survival

PLoS ONE

Volumn 7, Issue 1, 2012, Pages

  Lee, Cheng H ^a   Alpert, Benjamin O ^a,b   Sankaranarayanan, Preethi ^a,b   Alter, Orly ^a,b,c  

^a UNIVERSITY OF UTAH   (United States)

^b Department of Electrical and Computer Engineering   (United States)

^c UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER PROGNOSIS; CANCER SURVIVAL; CCNE1 GENE; CELL CYCLE REGULATION; CHROMOSOME NUMBER; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; COPY NUMBER VARIATION; DISEASE ASSOCIATION; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE FREQUENCY; GENE TARGETING; GENERALIZED SINGULAR VALUE DECOMPOSITION; GENETIC ASSOCIATION; GENETIC PROCEDURES; GENETIC VARIABILITY; GENOME ANALYSIS; GENOTYPE PHENOTYPE CORRELATION; GLIOBLASTOMA; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; KDM5A GENE; MOLECULAR PATHOLOGY; ONCOGENE; OUTCOME ASSESSMENT; PREDICTION; SURVIVAL TIME; TLK2 GENE; TREATMENT RESPONSE; VALIDATION PROCESS; X CHROMOSOME; AGED; BRAIN TUMOR; CASE CONTROL STUDY; CLUSTER ANALYSIS; COMPARATIVE STUDY; GENETICS; MALE; METHODOLOGY; MIDDLE AGED; MOLECULAR DIAGNOSIS; MORTALITY; PATHOLOGY; PHYSIOLOGY; PROGNOSIS; STATISTICAL ANALYSIS; STATISTICS; SURVIVAL; VALIDATION STUDY;

ADULT; AGED; AGED, 80 AND OVER; BRAIN NEOPLASMS; CASE-CONTROL STUDIES; CLUSTER ANALYSIS; COMPARATIVE GENOMIC HYBRIDIZATION; DATA INTERPRETATION, STATISTICAL; DNA COPY NUMBER VARIATIONS; FEMALE; GLIOBLASTOMA; HUMANS; MALE; MATCHED-PAIR ANALYSIS; MIDDLE AGED; MOLECULAR DIAGNOSTIC TECHNIQUES; PROGNOSIS; SURVIVAL ANALYSIS; VALIDATION STUDIES AS TOPIC;

EID: 84856105640     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0030098     Document Type: Article

References (42)

1. Purow B, Schiff D, (2009) Advances in the genetics of glioblastoma: are we reaching critical mass? Nat Rev Neurol 5: 419-426.
2. Wiltshire RN, Rasheed BK, Friedman HS, Friedman AH, Bigner SH, (2000) Comparative genetic patterns of glioblastoma multiforme: potential diagnostic tool for tumor classification. Neuro Oncol 2: 164-173.
3. Nigro JM, Misra A, Zhang L, Smirnov I, Colman H, et al. (2005) Integrated array-comparative genomic hybridization and expression array profiles identify clinically relevant molecular subtypes of glioblastoma. Cancer Res 65: 1678-1686.
4. Cancer Genome Atlas Research Network (2008) Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 455: 1061-1068.
5. Mischel PS, Shai R, Shi T, Horvath S, Lu KV, et al. (2003) Identification of molecular subtypes of glioblastoma by gene expression profiling. Oncogene 22: 2361-2673.
6. Verhaak RG, Hoadley KA, Purdom E, Wang V, Qi Y, et al. (2010) Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell 17: 98-110.
7. Colman H, Zhang L, Sulman EP, McDonald JM, Shooshtari NL, et al. (2010) A multigene predictor of outcome in glioblastoma. Neuro Oncol 12: 49-57.
8. Noushmehr H, Weisenberger DJ, Diefes K, Phillips HS, Pujara K, et al. (2010) Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma. Cancer Cell 17: 510-522.
9. Curran WJ Jr, Scott CB, Horton J, Nelson JS, Weinstein AS, et al. (1993) Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials. J Natl Cancer Inst 85: 704-710.
10. Gorlia T, van den Bent MJ, Hegi ME, Mirimanoff RO, Weller M, et al. (2008) Nomograms for predicting survival of patients with newly diagnosed glioblastoma: prognostic factor analysis of EORTC and NCIC trial 26981-22981/CE.3. Lancet Oncol 9: 29-38.
11. Golub GH, Van Loan CF, (1996) Matrix Computations Baltimore Johns Hopkins University Press, third edition.
12. Alter O, Brown PO, Botstein D, (2003) Generalized singular value decomposition for comparative analysis of genome-scale expression data sets of two different organisms. Proc Natl Acad Sci USA 100: 3351-3356.
13. Ponnapalli SP, Saunders MA, Van Loan CF, Alter O, (2011) A higher-order generalized singular value decomposition for comparison of global mRNA expression from multiple organisms. PLoS ONE 6: e28072.
14. Lee CH, Alter O, (2010) Known and novel copy number alterations in GBM and their patterns of co-occurrence are revealed by GSVD comparison of array CGH data from patient-matched normal and tumor TCGA samples. In: 60th Annual American Society of Human Genetics (ASHG) Meeting (November 2-6, 2010, Washington, DC).
15. Alpert BO, Sankaranarayanan P, Lee CH, Alter O, (2011) Glioblastoma multiforme prognosis by using a patient's array CGH tumor profile and a generalized SVD-computed global pattern of copy-number alterations. In: 2nd DNA and Genome World Day (April 25-29, 2011, Dalian, China).
16. Nielsen TO, West RB, Linn SC, Alter O, Knowling MA, et al. (2002) Molecular characterisation of soft tissue tumours: a gene expression study. Lancet 359: 1301-1307.
17. Tavazoie S, Hughes JD, Campbell MJ, Cho RJ, Church GM, (1999) Systematic determination of genetic network architecture. Nat Genet 22: 281-285.
18. Kent WJ, Sugnet CW, Furey TS, Roskin KM, Pringle TH, et al. (2002) The human genome browser at UCSC. Genome Res 12: 996-1006.
19. Fujita PA, Rhead B, Zweig AS, Hinrichs AS, Karolchik D, et al. (2011) The UCSC Genome Browser database: update 2011. Nucleic Acids Res 39: D876-D882.
20. Olshen AB, Venkatraman ES, Lucito R, Wigler M, (2004) Circular binary segmentation for the analysis of array-based DNA copy number data. Biostatistics 5: 557-572.
21. Venkatraman ES, Olshen AB, (2007) A faster circular binary segmentation algorithm for the analysis of array CGH data. Bioinformatics 23: 657-663.
22. Heidenblad M, Lindgren D, Veltman JA, Jonson T, Mahlamäki EH, et al. (2005) Microarray analyses reveal strong influence of DNA copy number alterations on the transcriptional patterns in pancreatic cancer: implications for the interpretation of genomic amplifications. Oncogene 24: 1794-1801.
23. Wang Q, Diskin S, Rappaport E, Attiyeh E, Mosse Y, et al. (2006) Integrative genomics identifies distinct molecular classes of neuroblastoma and shows that multiple genes are targeted by regional alterations in DNA copy number. Cancer Res 66: 6050-6062.
24. Hopkins AL, Groom CR, (2002) The druggable genome. Nat Rev Drug Discov 1: 727-730.
25. Silljé HH, Takahashi K, Tanaka K, Van Houwe G, Nigg EA, (1999) Mammalian homologues of the plant Tousled gene code for cell-cycle-regulated kinases with maximal activities linked to ongoing DNA replication. EMBO J 18: 5691-5702.
26. Chandran UR, Ma C, Dhir R, Bisceglia M, Lyons-Weiler M, et al. (2007) Gene expression profiles of prostate cancer reveal involvement of multiple molecular pathways in the metastatic process. BMC Cancer 7: 64.
27. Pellegrini M, Cheng JC, Voutila J, Judelson D, Taylor J, et al. (2008) Expression profile of CREB knockdown in myeloid leukemia cells. BMC Cancer 8: 264.
28. Millour M, Charbonnel C, Magrangeas F, Minvielle S, Campion L, et al. (2006) Gene expression profiles discriminate between pathological complete response and resistance to neoadjuvant FEC100 in breast cancer. Cancer Genomics Proteomics 3: 89-95.
29. Snijders AM, Nowee ME, Fridlyand J, Piek JM, Dorsman JC, et al. (2003) Genome-wide-array-based comparative genomic hybridization reveals genetic homogeneity and frequent copy number increases encompassing CCNE1 in fallopian tube carcinoma. Oncogene 22: 4281-4286.
30. Campbell PJ, Yachida S, Mudie LJ, Stephens PJ, Pleasance ED, et al. (2010) The patterns and dynamics of genomic instability in metastatic pancreatic cancer. Nature 467: 1109-1113.
31. Etemadmoghadam D, George J, Cowin PA, Cullinane C, Kansara M, et al. (2010) Amplicon-dependent CCNE1 expression is critical for clonogenic survival after cisplatin treatment and is correlated with 20q11 gain in ovarian cancer. PLoS ONE 5: e15498.
32. Defeo-Jones D, Huang PS, Jones RE, Haskell KM, Vuocolo GA, et al. (1991) Cloning of cDNAs for cellular proteins that bind to the retinoblastoma gene product. Nature 352: 251-254.
33. Sharma SV, Lee DY, Li B, Quinlan MP, Takahashi F, et al. (2010) A chromatin-mediated reversible drug-tolerant state in cancer cell subpopulations. Cell 141: 69-80.
34. Pardridge WM, (2005) The blood-brain barrier: bottleneck in brain drug development. NeuroRx 2: 3-14.
35. Hattori Y, Ohta S, Hamada K, Yamada-Okabe H, Kanemura Y, et al. (2007) Identification of a neuron-specific human gene, KIAA1110, that is a guanine nucleotide exchange factor for ARF1. Biochem Biophys Res Commun 364: 737-742.
36. Kaplan EL, Meier P, (1958) Nonparametric estimation from incomplete observations. J Amer Statist Assn 53: 457-481.
37. Cox DR, (1972) Regression models and life-tables. J Roy Statist Soc B 34: 187-220.
38. Rothman KJ, (1990) No adjustments are needed for multiple comparisons. Epidemiology 1: 43-46.
39. Alter O, (2006) Discovery of principles of nature from mathematical modeling of DNA microarray data. Proc Natl Acad Sci USA 103: 16063-16064.
40. Omberg L, Meyerson JR, Kobayashi K, Drury LS, Diffley JF, et al. (2009) Global effects of DNA replication and DNA replication origin activity on eukaryotic gene expression. Mol Syst Biol 5: 312.
41. Alter O, Golub GH, (2004) Integrative analysis of genome-scale data by using pseudoinverse projection predicts novel correlation between DNA replication and RNA transcription. Proc Natl Acad Sci USA 101: 16577-16582.
42. Omberg L, Golub GH, Alter O, (2007) A tensor higher-order singular value decomposition for integrative analysis of DNA microarray data from different studies. Proc Natl Acad Sci USA 104: 18371-18376.